The Cooper Companies, Inc. (COO)
NASDAQ: COO · IEX Real-Time Price · USD
97.31
-0.59 (-0.60%)
May 17, 2024, 4:00 PM EDT - Market closed

Company Description

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers.

The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.

The CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage to health care professionals and patients worldwide.

It offers surgical and office products, including endosee endometrial imaging products, fetal pillow cephalic elevation devices for use in cesarean sections, illuminated speculum products, lone star retractor systems, loop electrosurgical excision procedure products, mara water ablation systems, paragard contraceptive IUDs, point-of-care, and uterine positioning products, as well as cryostorage, such as cord blood and cord tissue storage; fertility products and services, such as fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing.

The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers.

The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

The Cooper Companies, Inc.
The Cooper Companies logo
Country United States
Founded 1980
Industry Medical Instruments & Supplies
Sector Healthcare
Employees 15,000
CEO Albert G. White III

Contact Details

Address:
6101 Bollinger Canyon Road, Suite 500
San Ramon, California 94583
United States
Phone (925) 460-3600
Website coopercos.com

Stock Details

Ticker Symbol COO
Exchange NASDAQ
Fiscal Year November - October
Reporting Currency USD
CIK Code 0000711404
CUSIP Number 216648402
ISIN Number US2166485019
Employer ID 94-2657368
SIC Code 3851

Key Executives

Name Position
Albert G. White III President, Chief Executive Officer and Non-Independent Director
Brian G. Andrews Executive Vice President, Chief Financial Officer and Treasurer
Daniel G. McBride Esq. Executive Vice President and Chief Operating Officer
Holly R. Sheffield President of CooperSurgical, Inc.
Gerard H. Warner III President of CooperVision, Inc.
Agostino Ricupati Senior Vice President and Chief Accounting Officer
Kim Duncan Vice President of Investor Relations and Risk Management
Nicholas S. Khadder General Counsel and Corporate Secretary

Latest SEC Filings

Date Type Title
May 1, 2024 8-K Current Report
Apr 18, 2024 144 Filing
Apr 9, 2024 144 Filing
Apr 4, 2024 144 Filing
Mar 22, 2024 8-K Current Report
Mar 18, 2024 144 Filing
Mar 7, 2024 144 Filing
Mar 5, 2024 144 Filing
Mar 1, 2024 10-Q Quarterly Report
Feb 29, 2024 8-K Current Report